Your browser doesn't support javascript.
loading
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.
Sinjab, Ansam; Han, Guangchun; Treekitkarnmongkol, Warapen; Hara, Kieko; Brennan, Patrick M; Dang, Minghao; Hao, Dapeng; Wang, Ruiping; Dai, Enyu; Dejima, Hitoshi; Zhang, Jiexin; Bogatenkova, Elena; Sanchez-Espiridion, Beatriz; Chang, Kyle; Little, Danielle R; Bazzi, Samer; Tran, Linh M; Krysan, Kostyantyn; Behrens, Carmen; Duose, Dzifa Y; Parra, Edwin R; Raso, Maria Gabriela; Solis, Luisa M; Fukuoka, Junya; Zhang, Jianjun; Sepesi, Boris; Cascone, Tina; Byers, Lauren Averett; Gibbons, Don L; Chen, Jichao; Moghaddam, Seyed Javad; Ostrin, Edwin J; Rosen, Daniel; Heymach, John V; Scheet, Paul; Dubinett, Steven M; Fujimoto, Junya; Wistuba, Ignacio I; Stevenson, Christopher S; Spira, Avrum; Wang, Linghua; Kadara, Humam.
Afiliación
  • Sinjab A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Treekitkarnmongkol W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hara K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Brennan PM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hao D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dai E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dejima H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Bioinformatics and Computer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bogatenkova E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sanchez-Espiridion B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang K; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Little DR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bazzi S; Faculty of Arts and Sciences, University of Balamand, Koura, Lebanon.
  • Tran LM; Department of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Krysan K; Department of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Behrens C; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Raso MG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Solis LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fukuoka J; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Zhang J; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sepesi B; Department of Cardiovascular and Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cascone T; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Byers LA; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gibbons DL; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen J; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moghaddam SJ; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ostrin EJ; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rosen D; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
  • Heymach JV; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Scheet P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dubinett SM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fujimoto J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Stevenson CS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Spira A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang L; Lung Cancer Initiative at Johnson and Johnson, Boston, Massachusetts.
  • Kadara H; Lung Cancer Initiative at Johnson and Johnson, Boston, Massachusetts.
Cancer Discov ; 11(10): 2506-2523, 2021 10.
Article en En | MEDLINE | ID: mdl-33972311
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Microambiente Tumoral / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Microambiente Tumoral / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article